Angiokeratoma regression in a Fabry disease after treatment with agalsidase-beta: clinical effectiveness marker?

Related Experiment Video

Updated: Jun 18, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
10:16

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

A L Fauchais, S Prey, B Ouatara

    Journal of the European Academy of Dermatology and Venereology : JEADV
    |November 21, 2009
    PubMed
    Abstract

    No abstract available in PubMed .

    Related Concept Videos